Efficacy of pegylated interferon plus ribavirin in combination with corticosteroid for two cases of combined hepatitis C and autoimmune hepatitis

[1]  S. Alavian,et al.  Autoimmune diseases co-existing with hepatitis C virus infection. , 2010, Iranian journal of allergy, asthma, and immunology.

[2]  Xiao-yuan Xu,et al.  [Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C]. , 2009, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology.

[3]  K. Boberg,et al.  Simplified criteria for the diagnosis of autoimmune hepatitis , 2008, Hepatology.

[4]  R. Coriat,et al.  Fulminant autoimmune hepatitis after successful interferon treatment in an HIV–HCV co-infected patient , 2008, International journal of STD & AIDS.

[5]  T. Kogure,et al.  Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment. , 2007, World journal of gastroenterology.

[6]  H. Kasper,et al.  Differential efficacy of corticosteroids and interferon in a patient with chronic hepatitis C-autoimmune hepatitis overlap syndrome. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  A. Czaja,et al.  The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants. , 2002, Clinics in liver disease.

[8]  T. Schiano,et al.  Results of steroid-based therapy for the hepatitis C–autoimmune hepatitis overlap syndrome , 2001, American Journal of Gastroenterology.

[9]  M. Manns,et al.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. , 1999, Journal of hepatology.

[10]  M. Omata,et al.  Present status of autoimmune hepatitis in Japan--correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. , 1997, Journal of hepatology.

[11]  M. Manns,et al.  Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C. , 1997, Journal of hepatology.

[12]  T. Schiano,et al.  Chronic Hepatitis with Combined Features of Autoimmune Chronic Hepatitis and Chronic Hepatitis C: Favorable Response to Prednisone and Azathioprine , 1995, Annals of Internal Medicine.

[13]  J. Hoofnagle,et al.  Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C. , 1992, Gastroenterology.

[14]  Q. Choo,et al.  Hepatitis C virus replication in 'autoimmune' chronic hepatitis. , 1991, Journal of hepatology.

[15]  N. Mulder,et al.  TRANSFUSION ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN AUTOLOGOUS BONE MARROW TRANSPLANTATION , 1989, The Lancet.

[16]  R. Stern,et al.  Controlled trial of prednisone and azathioprine in active chronic hepatitis. , 1973, Lancet.

[17]  L. Elveback,et al.  Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. , 1972, Gastroenterology.

[18]  S. Sherlock,et al.  Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. , 1971, The Quarterly journal of medicine.